HIVES SUMMIT 2026
Continuing Medical Education on
Urticaria, Angioedema and Drug Rash
Urticaria Beyond Antihistamines: Exploring New Frontiers
Organised by
Department of Dermatology, PGIMER, Chandigarh
24 & 25 October, 2026
About the Summit
Urticaria Beyond Antihistamines: Exploring New Frontiers
HIVES SUMMIT 2026 brings together leading dermatologists, immunologists, allergists, and researchers from across the globe to explore innovative approaches to urticaria management. Moving beyond antihistamines, this summit focuses on biologics, immunopathogenesis, and patient-centered care.
Urticaria, or hives, is a multifaceted condition that extends far beyond histamine-driven reactions. While antihistamines remain the first line of defense, emerging research reveals deeper immunological pathways involving mast cells, autoantibodies, and cytokines. The new frontier focuses on biologic therapies, precision medicine, and patient-centered care. By integrating immunology, dermatology, and technology, clinicians are redefining treatment strategies to achieve lasting remission and improved quality of life. This evolution marks a shift from symptomatic relief to targeted, evidence-based innovation—transforming urticaria management into a model of modern, multidisciplinary medicine.
2 Days
Intensive learning
30+ Speakers
World-renowned experts
300+ Delegates
Global networking
CME Accredited
Earn credits
Scientific Program Topics
HIVES SUMMIT 2026 delves into the latest research, therapies, and innovations shaping chronic urticaria care. Join our global faculty to explore these core themes:
1. Omalizumab and Next-Generation Biologics
Advances in monoclonal antibodies and novel biologics transforming urticaria care through targeted immune modulation and durable symptom control.
2. Chronic Spontaneous Urticaria Pathophysiology
Insights into immune mechanisms, mast cell activation, and molecular pathways driving persistent urticaria beyond histamine-mediated responses.
3. Refractory Urticaria Management Strategies
Practical solutions for antihistamine-refractory cases, including biologics, immunomodulators, and emerging stepwise treatment algorithms.
4. Patient-Centered Care Approaches
Promoting holistic management through patient-reported outcomes, shared decision-making, and long-term quality-of-life improvement.
5. Emerging Biomarkers and Diagnostics
Exploring novel molecular markers, autoantibodies, and diagnostic assays guiding precision medicine in chronic urticaria.
About Chandigarh
Nestled at the foothills of the Shivalik range, Chandigarh emerges as a shining testament to modern India’s visionary urban planning and architectural elegance. Revered as “The City Beautiful” it captivates with its verdant landscapes, serene gardens, and iconic design. From the tranquil expanse of Sukhna Lake to the imaginative brilliance of the Rock Garden, the city offers a seamless fusion of nature and human creativity. Its meticulously planned layout and vibrant cultural spirit transform it from a mere destination into an immersive experience that leaves every visitor inspired.
Enhancing the city’s distinguished stature is the prestigious Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, a beacon of excellence in medical education, pioneering research, and compassionate patient care.
In this inspiring milieu, we are proud to present the HIVES Summit 2026, built around the compelling theme “Beyond the Wheal: Understanding Urticaria.“
